SGR-1505
Product Specifications
CAS Number
2661481-41-8
Target
MALT
Related Pathways
Immunology/Inflammation
Bioactivity
SGR-1505, an orally active MALT1 allosteric inhibitor, reduces MALT1 enzymatic activity and demonstrates anti-proliferative effects in both BTK inhibitor (BTKi) -sensitive and BTKi-resistant activated B cell-like diffuse large B cell lymphoma (ABC-DLBCL) cell lines. SGR-1505 is applicable for B-cell lymphoma research [1].
Smiles
C(F)(F)(F)[C@@]1(C)C2=C(N(C(NC=3C=C(Cl)C(=NC3)N4N=CC=N4)=O)C1)C=NC=5N2N=C(F)C5
Molecular Formula
C18H12ClF4N9O
Molecular Weight
481.79
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1109635-01 0.02 mg (E-Coli)
Recombinant Archaeoglobus fulgidus Uncharacterized protein AF_0182 (AF_0182)
Sign In for Pricing
View Details 
MBS1109635-02 0.02 mg (Yeast)
Recombinant Archaeoglobus fulgidus Uncharacterized protein AF_0182 (AF_0182)
Sign In for Pricing
View Details MBS1109635-03 0.1 mg (E-Coli)
Recombinant Archaeoglobus fulgidus Uncharacterized protein AF_0182 (AF_0182)
Sign In for Pricing
View Details 
MBS1109635-04 0.1 mg (Yeast)
Recombinant Archaeoglobus fulgidus Uncharacterized protein AF_0182 (AF_0182)
Sign In for Pricing
View Details MBS1109635-05 0.02 mg (Baculovirus)
Recombinant Archaeoglobus fulgidus Uncharacterized protein AF_0182 (AF_0182)
Sign In for Pricing
View Details MBS1109635-06 0.02 mg (Mammalian-Cell)
Recombinant Archaeoglobus fulgidus Uncharacterized protein AF_0182 (AF_0182)
Sign In for Pricing
View Details